Aug 3, 2009 by Brian Orelli, PhDThe Roller-Coaster Stock That Keeps on GivingSavient's gout treatment isn't approved just yet.
Jul 31, 2009 by Brian Orelli, PhDMake Money Off Baby BoomersThey're getting older whether they like it or not.
Jul 31, 2009 by Brian Orelli, PhDTwo Pictures of a Drug CompanyWho should we believe? The FDA? Mylan's earnings report?
Jul 31, 2009 by Brian Orelli, PhDA Health-Care Investor's NightmareThe unknown may be worse than the worst known.
Jul 31, 2009 by Brian Orelli, PhDCan Emerging Markets Save Pharma?Probably not until after they emerge.
Jul 30, 2009 by Brian Orelli, PhDMerck, Sanofi, and Schering's Love TrianglePerhaps the most complicated deal of the year.
Jul 30, 2009 by Brian Orelli, PhDA Good Business Model for Bad TimesSome businesses benefit when people are hurting.
Jul 29, 2009 by Brian Orelli, PhDIgnore These Companies at Your PerilYou may not want to invest in them, but don't ignore them.
Jul 28, 2009 by Brian Orelli, PhDI Can't Believe My Company Got AcquiredWould you like some cheese with that whining?
Jul 28, 2009 by Brian Orelli, PhDAmgen Secures Its FutureEarnings and a marketing partnership -- oh my.
Jul 27, 2009 by Brian Orelli, PhDMylan Ruins It for EveryoneDon't mess with standard operating procedures.
Jul 23, 2009 by Brian Orelli, PhDThis Too Shall Pass ... Like a Kidney StoneDemand outstrips supply? Boo-hoo.
